PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | |type 2 diabetes |
| Sentences | 223 |
| PubMedID- 20167181 | Epidemiology of cardiovascular disease in type 2 diabetes: the indian scenario. |
| PubMedID- 23011351 | Conclusions/interpretation: treatment with esomeprazole over 12 weeks did not improve insulin secretion, glycaemic control or cardiovascular disease biomarkers in patients with type 2 diabetes. |
| PubMedID- 25861721 | Relationships between the risk of cardiovascular disease in type 2 diabetes patients and both visit-to-visit variability and time-to-effect differences in blood pressure. |
| PubMedID- 20052788 | Correction: glucose control and cardiovascular disease in type 2 diabetes. |
| PubMedID- 21525439 | Accord (action to control cardiovascular risk in diabetes) was specifically designed to determine the effects of intensive treatment of blood glucose, and either blood pressure (accord blood pressure) or plasma lipids (accord lipid), on atherosclerotic cardiovascular disease outcomes in patients with type 2 diabetes who were at high risk of such an outcome (6). |
| PubMedID- 26429401 | Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in sweden: a nationwide, matched, observational cohort study. |
| PubMedID- 25527522 | Conclusions: in our series, type 2 diabetes mellitus patients with cardiovascular disease at baseline present with an increased risk of developing diabetic peripheral neuropathy at 10 years of follow-up. |
| PubMedID- 21109113 | Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the advance (action in diabetes and vascular disease: preterax and diamicron modified-release controlled evaluation) trial. |
| PubMedID- 26504840 | Hypoglycaemia, abnormal lipids, and cardiovascular disease among chinese with type 2 diabetes. |
| PubMedID- 21227617 | Purpose: to clarify the differences of the carotid and cerebrovascular disease between patients with and without type 2 diabetes using dual-source ct angiography. |
| PubMedID- 25813652 | Objective: we evaluate the association between the decrease of serum paraxonase 1 activity and the risk of cardiovascular disease in type 2 diabetes. |
| PubMedID- 25554536 | Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease. |
| PubMedID- 21078616 | The contribution of the hemostatic system in the development of cardiovascular disease (cvd) in patients with type 2 diabetes is not completely defined. |
| PubMedID- 25238222 | What is it about very low density lipoproteins (vldl) and cardiovascular disease in patients with type 2 diabetes mellitus: is it the triglycerides or the cholesterol. |
| PubMedID- 24843558 | Aims/introduction: to reveal whether visit-to-visit variability in hba1c is associated with higher risk of cardiovascular disease (cvd) in patients with type 2 diabetes. |
| PubMedID- 23278364 | Aims: to analyse the effects of hyperglycaemia and blood pressure, diabetes and anti-hypertension treatment on total and various types of cardiovascular disease incidence in patients with type 2 diabetes followed for 30 years. |
| PubMedID- 26186882 | Erratum to: favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the fenofibrate intervention and event lowering in diabetes (field) study. |
| PubMedID- 21674176 | Additive effects of glycaemia and dyslipidaemia on risk of cardiovascular diseases in type 2 diabetes: an observational study from the swedish national diabetes register. |
| PubMedID- 26089896 | The results of this study indicated unfavorable upward trends in serum lipid levels and in the prevalence of dyslipidemia, chd, and cerebrovascular disease among patients with newly diagnosed type 2 diabetes mellitus in the southwest chinese han population. |
| PubMedID- 24579534 | Pattern of dyslipidemia and evaluation of non-hdl cholesterol as a marker of risk factor for cardiovascular disease in type 2 diabetes mellitus. |
| PubMedID- 26207061 | Patient empowerment programme (pep) and risk of microvascular diseases among patients with type 2 diabetes in primary care: a population-based propensity-matched cohort study. |
| PubMedID- 21719139 | A new model for 5-year risk of cardiovascular disease in type 2 diabetes, from the swedish national diabetes register (ndr). |
| PubMedID- 23264288 | After full-text review of 33 articles, 15 studies were excluded because they were missing sufficient data, did not report rr or hr estimates, and assessed cardiovascular disease with type 2 diabetes or genetic variants of crp. |